APR 17, 2020 10:39 AM PDT

A Brief History: The Search for the Perfect High

WRITTEN BY: C Reardon

With cannabis landing closely behind alcohol as the most widely used recreational drug in the United States, researchers and cannabis professionals race to uncover the scientific secrets behind the "perfect high."

Unlike alcohol, a somewhat predictable and tightly regulated psychoactive drug, cannabis is often a mystery regarding the way it will affect a consumer in smaller doses, as it has the potential to trigger widely varying symptoms depending on the strain and the context in which it is taken.

Photo Source: Pixabay.com

Research to uncover what makes cannabis react differently in the human body dates back many years. In 1964 Israeli researcher Raphael Mechoulam was the first scientist to identify THC as the psychoactive molecule that gives users the "high." 

In 1998 Mechoulam coined the term "entourage effect" to identify and explain the complicated relationship between cannabinoids (cannabinoids are naturally occurring compounds found in the cannabis plant) and the neurotransmitters in the body. There are over 100 cannabinoids identified, but THC and cannabidiol (CBD) are the main cannabinoids found in the cannabis plant. He believed that this complicated, always varying relationship was the reason for unpredictable user experience.

Around the same time that Mechoulam was making scientific strides in the area of cannabinoids, research by American neurologist Ethan Russo recognized that terpenes, the aromatic oils that give different varieties of cannabis, as well as other plants, distinctive flavors and smells, could also be responsible for the variability in the effects of the drug.  

Through his research, Russo found that pure THC had adverse effects on mood and perception, but when a terpene was present, these effects could be changed drastically.

"It was my turn to make dinner that night, and it was like: 'Oh, God, I'm not sure I can do this. Where's the knife? What do I need to do next?' Everything was so hard," explains Russo as he recounts his personal experience on pure THC to The New York Times Magazine. He found that when he added pinene, the terpene that gives pinewoods their smell, or limonene, a terpene responsible for the citrus scent, that he was much clearer and able to perform everyday tasks, like making dinner.

Russo published a paper called "Taming THC," compiling over 400 studies supporting the claim that terpenes play a role in the variable effects of cannabis. 

Photo Source: Pixabay.com

In 2016 a company called Ebbu, a cannabis company first known for its plan to release a "Feelings" line of cannabis products, announced that they had identified eight terpenes, along with three cannabinoids, that would predictably alter the way THC affected the body.

A recent article published in The New York Times Magazine suggests that as scientists work to eliminate the present variability in the cannabis market in hopes of finding a predictable product to sell consumers, we may run the risk of removing the plant altogether. The author points out that Ebbu has patented a inkjet printer that prints both cannabinoids and terpenes in specific ratios in hopes of maintaining a predictable user experience. These inkjets could mean more manufacturing and less growing for the cannabis industry.

For further information on the scientific search for the perfect high visit The New York Times Magazine 

Sources: The New York Times Magazine

 

 

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
JUL 16, 2020
Clinical & Molecular DX
AI Platform Alerts to the Earliest Signs of COVID-Related Pneumonia
JUL 16, 2020
AI Platform Alerts to the Earliest Signs of COVID-Related Pneumonia
Severe cases of COVID-19 can cause pneumonia, a process whereby the delicate air sacs in the lungs swell with fluid, and ...
JUL 14, 2020
Immunology
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
JUL 14, 2020
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
Scientists are working on developing an arsenal of nano-sized weapons in the war against COVID-19. These molecules, call ...
JUL 15, 2020
Cancer
Traditional Medicine Reveals a New Anti-Cancer Drug
JUL 15, 2020
Traditional Medicine Reveals a New Anti-Cancer Drug
The art of traditional eastern medicine dates back thousands of years. It uses many unproven remedies, and many consider ...
AUG 04, 2020
Clinical & Molecular DX
Alzheimer's Blood Test Serves as a Crystal Ball
AUG 04, 2020
Alzheimer's Blood Test Serves as a Crystal Ball
According to a recent study, the answers could lie in a simple blood test.
AUG 12, 2020
Cancer
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
AUG 12, 2020
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
Since the 1940s, chemotherapy has been a primary treatment option for cancer. The late 20th century brought a new type o ...
AUG 11, 2020
Drug Discovery & Development
FDA Approves New Opioid for Short-Term Use
AUG 11, 2020
FDA Approves New Opioid for Short-Term Use
The US Food and Drug Administration has announced the approval of Olinvyk (oliceridine), a new opioid that can help mana ...
Loading Comments...